Literature DB >> 26201913

Role of cytokine levels in assessment of prognosis and post-treatment outcome in hepatocellular carcinoma.

Moana Gelu-Simeon1, Didier Samuel2,3,4.   

Abstract

Entities:  

Year:  2013        PMID： 26201913     DOI： 10.1007/s12072-013-9441-4

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  23 in total

Review 1.  Angiogenesis and hepatocellular carcinoma.

Authors:  David Semela; Jean-François Dufour
Journal:  J Hepatol       Date:  2004-11       Impact factor: 25.083

Review 2.  The biology of interleukin-6.

Authors:  T Kishimoto
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

3.  Clinical relevance of antibiotic-induced endotoxin release in patients undergoing hepatic resection.

Authors:  M Ishikawa; T Miyauchi; K Yagi; H Chikaishi; Y Fukuta; H Miyake; M Harada; S Yogita; S Tashiro
Journal:  World J Surg       Date:  1999-01       Impact factor: 3.352

4.  Effect of vascular endothelial growth factor on functional recovery after hepatectomy in lean and obese mice.

Authors:  Claudio A Redaelli; David Semela; Francine E Carrick; Monika Ledermann; Daniel Candinas; Bernhard Sauter; Jean-François Dufour
Journal:  J Hepatol       Date:  2004-02       Impact factor: 25.083

5.  Analysis of host response to hepatectomy by simultaneous measurement of cytokines in the portal vein, caval vein and radial artery.

Authors:  Y Kanaoka; T Yagi; H Sadamori; H Matsukawa; H Matsuda; M Inagaki; T Ishikawa; S Saito; H Iwagaki; N Tanaka
Journal:  J Int Med Res       Date:  2002 Sep-Oct       Impact factor: 1.671

6.  Acute portal hemodynamics and cytokine changesfollowing selective transarterial chemoembolization in patients with cirrhosis and hepatocellular carcinoma.

Authors:  Laurent Spahr; Christoph Becker; Jérôme Pugin; Pietro E Majno; Antonine Hadengue
Journal:  Med Sci Monit       Date:  2003-09

7.  Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?

Authors:  Fabio Farinati; Dario Marino; Massimo De Giorgio; Anna Baldan; Maria Cantarini; Carmela Cursaro; Gianludovico Rapaccini; Paolo Del Poggio; Maria Anna Di Nolfo; Luisa Benvegnù; Marco Zoli; Franco Borzio; Mauro Bernardi; Franco Trevisani
Journal:  Am J Gastroenterol       Date:  2006-03       Impact factor: 10.864

8.  Preoperative and postoperative cytokines in patients with cancer.

Authors:  H Nakazaki
Journal:  Cancer       Date:  1992-08-01       Impact factor: 6.860

9.  Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer.

Authors:  M Bortolami; C Venturi; L Giacomelli; R Scalerta; S Bacchetti; F Marino; A Floreani; M Lise; R Naccarato; F Farinati
Journal:  Dig Liver Dis       Date:  2002-11       Impact factor: 4.088

10.  Elevated pretherapy serum IL17 in primary hepatocellular carcinoma patients correlate to increased risk of early recurrence after curative hepatectomy.

Authors:  Jianxiong Wu; Jun Du; Liguo Liu; Qian Li; Weiqi Rong; Liming Wang; Ying Wang; Mengya Zang; Zhiyuan Wu; Yawei Zhang; Chunfeng Qu
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240
View more
  2 in total

Review 1.  Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma.

Authors:  Vikrant Rai; Joe Abdo; Abdullah N Alsuwaidan; Swati Agrawal; Poonam Sharma; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2017-06-07       Impact factor: 3.842

2.  Sulfasalazine synergistically enhances the inhibitory effects of imatinib against hepatocellular carcinoma (HCC) cells by targeting NFκB, BCR/ABL, and PI3K/AKT signaling pathway-related proteins.

Authors:  Marium M Shamaa
Journal:  FEBS Open Bio       Date:  2021-02-20       Impact factor: 2.693
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.